Prof. Mark Weiser

Psychiatry
School of Continuing Medical Education
פסיכיאטריה סגל אקדמי קליני
Quick navigation:
Prof. Mark Weiser
Phone: 3773
External phone: 03-5303773
Fax: 03-5353807

Education

PUBLICATIONS

1.  Weiser M, Levi L, Burshtein S, Chirita R, Cirjaliu D, Gonen I, Yolken R, Davidson M, Zamora D, Davis JM. The effect of minocycline on symptoms in schizophrenia: Results from a randomized controlled trial. Schizophr Res. 2018.

2.  Popovic D, Goldberg S, Fenchel D, Frenkel O, Reichenberg A, Yoffe R, Davidson M, Weiser M. Risk of hospitalization for psychiatric disorders among siblings and parents of probands with psychotic or affective disorders: A population-based study. Eur Neuropsychopharmacol. 2018;28:436-443.

3.  Livny A, Reichenberg A, Fruchter E, Yoffe R, Goldberg S, Fenchel D, Burshtein S, Bachar E, Davidson M, Weiser M. A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis. Am J Psychiatry. 2018;175:351-358.

4.  Levi O, Fruchter E, Weiser M, Pine DS, Kreiss Y, Bar-Haim Y. Treatment Seeking for Posttraumatic Stress in Israel Defense Forces Veterans Deployed in the 2006 Israel-Hezbollah War: A 7-Year Post-War Follow-Up. Isr J Psychiatry Relat Sci. 2018;55:4-9.

5.  Large M, Myles N, Myles H, Corderoy A, Weiser M, Davidson M, Ryan CJ. Suicide risk assessment among psychiatric inpatients: a systematic review and meta-analysis of high-risk categories. Psychol Med. 2018;48:1119-1127.

6.  Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Diaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthoj B, Eijkemans MJC, Fleischhacker WW, Kapur S, Sommer IE, group OPs. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. Lancet Psychiatry. 2018;5:797-807.

7.  Brainstorm C, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R, Patsopoulos NA, Ripke S, Wei Z, Yu D, Lee PH, Turley P, Grenier-Boley B, Chouraki V, Kamatani Y, Berr C, Letenneur L, Hannequin D, Amouyel P, Boland A, Deleuze JF, Duron E, Vardarajan BN, Reitz C, Goate AM, Huentelman MJ, Kamboh MI, Larson EB, Rogaeva E, St George-Hyslop P, Hakonarson H, Kukull WA, Farrer LA, Barnes LL, Beach TG, Demirci FY, Head E, Hulette CM, Jicha GA, Kauwe JSK, Kaye JA, Leverenz JB, Levey AI, Lieberman AP, Pankratz VS, Poon WW, Quinn JF, Saykin AJ, Schneider LS, Smith AG, Sonnen JA, Stern RA, Van Deerlin VM, Van Eldik LJ, Harold D, Russo G, Rubinsztein DC, Bayer A, Tsolaki M, Proitsi P, Fox NC, Hampel H, Owen MJ, Mead S, Passmore P, Morgan K, Nothen MM, Rossor M, Lupton MK, Hoffmann P, Kornhuber J, Lawlor B, McQuillin A, Al-Chalabi A, Bis JC, Ruiz A, Boada M, Seshadri S, Beiser A, Rice K, van der Lee SJ, De Jager PL, Geschwind DH, Riemenschneider M, Riedel-Heller S, Rotter JI, Ransmayr G, Hyman BT, Cruchaga C, Alegret M, Winsvold B, Palta P, Farh KH, Cuenca-Leon E, Furlotte N, Kurth T, Ligthart L, Terwindt GM, Freilinger T, Ran C, Gordon SD, Borck G, Adams HHH, Lehtimaki T, Wedenoja J, Buring JE, Schurks M, Hrafnsdottir M, Hottenga JJ, Penninx B, Artto V, Kaunisto M, Vepsalainen S, Martin NG, Montgomery GW, Kurki MI, Hamalainen E, Huang H, Huang J, Sandor C, Webber C, Muller-Myhsok B, Schreiber S, Salomaa V, Loehrer E, Gobel H, Macaya A, Pozo-Rosich P, Hansen T, Werge T, Kaprio J, Metspalu A, Kubisch C, Ferrari MD, Belin AC, van den Maagdenberg A, Zwart JA, Boomsma D, Eriksson N, Olesen J, Chasman DI, Nyholt DR, Avbersek A, Baum L, Berkovic S, Bradfield J, Buono R, Catarino CB, Cossette P, De Jonghe P, Depondt C, Dlugos D, Ferraro TN, French J, Hjalgrim H, Jamnadas-Khoda J, Kalviainen R, Kunz WS, Lerche H, Leu C, Lindhout D, Lo W, Lowenstein D, McCormack M, Moller RS, Molloy A, Ng PW, Oliver K, Privitera M, Radtke R, Ruppert AK, Sander T, Schachter S, Schankin C, Scheffer I, Schoch S, Sisodiya SM, Smith P, Sperling M, Striano P, Surges R, Thomas GN, Visscher F, Whelan CD, Zara F, Heinzen EL, Marson A, Becker F, Stroink H, Zimprich F, Gasser T, Gibbs R, Heutink P, Martinez M, Morris HR, Sharma M, Ryten M, Mok KY, Pulit S, Bevan S, Holliday E, Attia J, Battey T, Boncoraglio G, Thijs V, Chen WM, Mitchell B, Rothwell P, Sharma P, Sudlow C, Vicente A, Markus H, Kourkoulis C, Pera J, Raffeld M, Silliman S, Boraska Perica V, Thornton LM, Huckins LM, William Rayner N, Lewis CM, Gratacos M, Rybakowski F, Keski-Rahkonen A, Raevuori A, Hudson JI, Reichborn-Kjennerud T, Monteleone P, Karwautz A, Mannik K, Baker JH, O'Toole JK, Trace SE, Davis OSP, Helder SG, Ehrlich S, Herpertz-Dahlmann B, Danner UN, van Elburg AA, Clementi M, Forzan M, Docampo E, Lissowska J, Hauser J, Tortorella A, Maj M, Gonidakis F, Tziouvas K, Papezova H, Yilmaz Z, Wagner G, Cohen-Woods S, Herms S, Julia A, Rabionet R, Dick DM, Ripatti S, Andreassen OA, Espeseth T, Lundervold AJ, Steen VM, Pinto D, Scherer SW, Aschauer H, Schosser A, Alfredsson L, Padyukov L, Halmi KA, Mitchell J, Strober M, Bergen AW, Kaye W, Szatkiewicz JP, Cormand B, Ramos-Quiroga JA, Sanchez-Mora C, Ribases M, Casas M, Hervas A, Arranz MJ, Haavik J, Zayats T, Johansson S, Williams N, Dempfle A, Rothenberger A, Kuntsi J, Oades RD, Banaschewski T, Franke B, Buitelaar JK, Arias Vasquez A, Doyle AE, Reif A, Lesch KP, Freitag C, Rivero O, Palmason H, Romanos M, Langley K, Rietschel M, Witt SH, Dalsgaard S, Borglum AD, Waldman I, Wilmot B, Molly N, Bau CHD, Crosbie J, Schachar R, Loo SK, McGough JJ, Grevet EH, Medland SE, Robinson E, Weiss LA, Bacchelli E, Bailey A, Bal V, Battaglia A, Betancur C, Bolton P, Cantor R, Celestino-Soper P, Dawson G, De Rubeis S, Duque F, Green A, Klauck SM, Leboyer M, Levitt P, Maestrini E, Mane S, De-Luca DM, Parr J, Regan R, Reichenberg A, Sandin S, Vorstman J, Wassink T, Wijsman E, Cook E, Santangelo S, Delorme R, Roge B, Magalhaes T, Arking D, Schulze TG, Thompson RC, Strohmaier J, Matthews K, Melle I, Morris D, Blackwood D, McIntosh A, Bergen SE, Schalling M, Jamain S, Maaser A, Fischer SB, Reinbold CS, Fullerton JM, Guzman-Parra J, Mayoral F, Schofield PR, Cichon S, Muhleisen TW, Degenhardt F, Schumacher J, Bauer M, Mitchell PB, Gershon ES, Rice J, Potash JB, Zandi PP, Craddock N, Ferrier IN, Alda M, Rouleau GA, Turecki G, Ophoff R, Pato C, Anjorin A, Stahl E, Leber M, Czerski PM, Cruceanu C, Jones IR, Posthuma D, Andlauer TFM, Forstner AJ, Streit F, Baune BT, Air T, Sinnamon G, Wray NR, MacIntyre DJ, Porteous D, Homuth G, Rivera M, Grove J, Middeldorp CM, Hickie I, Pergadia M, Mehta D, Smit JH, Jansen R, de Geus E, Dunn E, Li QS, Nauck M, Schoevers RA, Beekman AT, Knowles JA, Viktorin A, Arnold P, Barr CL, Bedoya-Berrio G, Bienvenu OJ, Brentani H, Burton C, Camarena B, Cappi C, Cath D, Cavallini M, Cusi D, Darrow S, Denys D, Derks EM, Dietrich A, Fernandez T, Figee M, Freimer N, Gerber G, Grados M, Greenberg E, Hanna GL, Hartmann A, Hirschtritt ME, Hoekstra PJ, Huang A, Huyser C, Illmann C, Jenike M, Kuperman S, Leventhal B, Lochner C, Lyon GJ, Macciardi F, Madruga-Garrido M, Malaty IA, Maras A, McGrath L, Miguel EC, Mir P, Nestadt G, Nicolini H, Okun MS, Pakstis A, Paschou P, Piacentini J, Pittenger C, Plessen K, Ramensky V, Ramos EM, Reus V, Richter MA, Riddle MA, Robertson MM, Roessner V, Rosario M, Samuels JF, Sandor P, Stein DJ, Tsetsos F, Van Nieuwerburgh F, Weatherall S, Wendland JR, Wolanczyk T, Worbe Y, Zai G, Goes FS, McLaughlin N, Nestadt PS, Grabe HJ, Depienne C, Konkashbaev A, Lanzagorta N, Valencia-Duarte A, Bramon E, Buccola N, Cahn W, Cairns M, Chong SA, Cohen D, Crespo-Facorro B, Crowley J, Davidson M, DeLisi L, Dinan T, Donohoe G, Drapeau E, Duan J, Haan L, Hougaard D, Karachanak-Yankova S, Khrunin A, Klovins J, Kucinskas V, Lee Chee Keong J, Limborska S, Loughland C, Lonnqvist J, Maher B, Mattheisen M, McDonald C, Murphy KC, Nenadic I, van Os J, Pantelis C, Pato M, Petryshen T, Quested D, Roussos P, Sanders AR, Schall U, Schwab SG, Sim K, So HC, Stogmann E, Subramaniam M, Toncheva D, Waddington J, Walters J, Weiser M, Cheng W, Cloninger R, Curtis D, Gejman PV, Henskens F, Mattingsdal M, Oh SY, Scott R, Webb B, Breen G, Churchhouse C, Bulik CM, Daly M, Dichgans M, Faraone SV, Guerreiro R, Holmans P, Kendler KS, Koeleman B, Mathews CA, Price A, Scharf J, Sklar P, Williams J, Wood NW, Cotsapas C, Palotie A, Smoller JW, Sullivan P, Rosand J, Corvin A, Neale BM, Schott JM, Anney R, Elia J, Grigoroiu-Serbanescu M, Edenberg HJ, Murray R. Analysis of shared heritability in common disorders of the brain. Science. 2018;360.

8.  Weiser M, Levi L, Levine SZ, Bialer M, Shekh-Ahmad T, Matei V, Tiugan A, Cirjaliu D, Sava C, Sinita E, Zamora D, Davis JM. A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania. Bipolar Disord. 2017;19:285-294.

9.  Weiser M, Levi L, Burshtein S, Hagin M, Matei VP, Podea D, Miclutia I, Tiugan A, Pacala B, Grecu IG, Noy A, Zamora D, Davis JM. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial. J Clin Psychiatry. 2017;78:e758-e765.

10.  Weiser M, Fenchel D, Werbeloff N, Goldberg S, Fruchter E, Reichenberg A, Burshtein S, Large M, Davidson M, Lubin G. The association between premorbid cognitive ability and social functioning and suicide among young men: A historical-prospective cohort study. Eur Neuropsychopharmacol. 2017;27:1-7.

11.  Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA, Jr., Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodriguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kahler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lonnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Muller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T, Psychosis Endophenotypes International C, Perkins DO, Pers TH, Pietilainen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Soderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jonsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nothen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J, Cnv, Schizophrenia Working Groups of the Psychiatric Genomics C. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet. 2017;49:27-35.

12.  Livny A, Biegon A, Kushnir T, Harnof S, Hoffmann C, Fruchter E, Weiser M. Cognitive Deficits Post-Traumatic Brain Injury and Their Association with Injury Severity and Gray Matter Volumes. J Neurotrauma. 2017;34:1466-1472.

13.  Large MM, Chung DT, Davidson M, Weiser M, Ryan CJ. In-patient suicide: selection of people at risk, failure of protection and the possibility of causation. BJPsych Open. 2017;3:102-105.

14.  Fruchter E, Beck-Fruchter R, Hourvitz A, Weiser M, Goldberg S, Fenchel D, Lerner-Geva L. Health and functioning of adolescents conceived by assisted reproductive technology. Fertil Steril. 2017;107:774-780.

15.  Davidson M, Saoud J, Staner C, Noel N, Luthringer E, Werner S, Reilly J, Schaffhauser JY, Rabinowitz J, Weiser M, Luthringer R. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. Am J Psychiatry. 2017;174:1195-1202.

16.  Amiaz R, Asher E, Rozen G, Czerniak E, Levi L, Weiser M, Glikson M. Reduction in depressive symptoms in primary prevention ICD scheduled patients - One year prospective study. Gen Hosp Psychiatry. 2017;48:37-41.

17.  Werbeloff N, Dohrenwend BP, Levav I, Haklai Z, Yoffe R, Large M, Davidson M, Weiser M. Demographic, Behavioral, and Psychiatric Risk Factors for Suicide. Crisis. 2016;37:104-111.

18.  Weiser M, Goldberg S, Werbeloff N, Fenchel D, Reichenberg A, Shelef L, Large M, Davidson M, Fruchter E. Risk of completed suicide in 89,049 young males assessed by a mental health professional. Eur Neuropsychopharmacol. 2016;26:341-349.

19.  Velthorst E, Reichenberg A, Kapra O, Goldberg S, Fromer M, Fruchter E, Ginat K, de Haan L, Davidson M, Weiser M. Developmental Trajectories of Impaired Community Functioning in Schizophrenia. JAMA Psychiatry. 2016;73:48-55.

20.  Trakhtenbrot R, Gvion Y, Levi-Belz Y, Horesh N, Fischel T, Weiser M, Treves I, Apter A. Predictive value of psychological characteristics and suicide history on medical lethality of suicide attempts: A follow-up study of hospitalized patients. J Affect Disord. 2016;199:73-80.

21.  Smith RC, Amiaz R, Si TM, Maayan L, Jin H, Boules S, Sershen H, Li C, Ren J, Liu Y, Youseff M, Lajtha A, Guidotti A, Weiser M, Davis JM. Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial. PLoS One. 2016;11:e0143490.

22.  Reichenberg A, Cederlof M, McMillan A, Trzaskowski M, Kapra O, Fruchter E, Ginat K, Davidson M, Weiser M, Larsson H, Plomin R, Lichtenstein P. Discontinuity in the genetic and environmental causes of the intellectual disability spectrum. Proc Natl Acad Sci U S A. 2016;113:1098-1103.

23.  Mehta D, Tropf FC, Gratten J, Bakshi A, Zhu Z, Bacanu SA, Hemani G, Magnusson PK, Barban N, Esko T, Metspalu A, Snieder H, Mowry BJ, Kendler KS, Yang J, Visscher PM, McGrath JJ, Mills MC, Wray NR, Lee SH, Schizophrenia Working Group of the Psychiatric Genomics Consortium LCS, TwinsUk, Andreassen OA, Bramon E, Bruggeman R, Buxbaum JD, Cairns MJ, Cantor RM, Cloninger CR, Cohen D, Crespo-Facorro B, Darvasi A, DeLisi LE, Dinan T, Djurovic S, Donohoe G, Drapeau E, Escott-Price V, Freimer NB, Georgieva L, de Haan L, Henskens FA, Joa I, Julia A, Khrunin A, Lerer B, Limborska S, Loughland CM, Macek M, Jr., Magnusson PK, Marsal S, McCarley RW, McIntosh AM, McQuillin A, Melegh B, Michie PT, Morris DW, Murphy KC, Myin-Germeys I, Olincy A, Van Os J, Pantelis C, Posthuma D, Quested D, Schall U, Scott RJ, Seidman LJ, Toncheva D, Tooney PA, Waddington J, Weinberger DR, Weiser M, Wu JQ. Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. JAMA Psychiatry. 2016;73:497-505.

24.  Levi L, Werbeloff N, Pugachova I, Yoffe R, Large M, Davidson M, Weiser M. Has deinstitutionalization affected inpatient suicide? Psychiatric inpatient suicide rates between 1990 and 2013 in Israel. Schizophr Res. 2016;173:75-78.

25.  Fruchter E, Marom-Harel H, Fenchel D, Kapra O, Ginat K, Portuguese S, Weiser M. Functioning of Young Adults With ADHD in the Military. J Atten Disord. 2016:1087054716652478.

26.  Feingold D, Weiser M, Rehm J, Lev-Ran S. The association between cannabis use and anxiety disorders: Results from a population-based representative sample. Eur Neuropsychopharmacol. 2016;26:493-505.

27.  Epstein T, Patsopoulos NA, Weiser M. WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2016:CD005041.

28.  Davidson M, Kapara O, Goldberg S, Yoffe R, Noy S, Weiser M. A Nation-Wide Study on the Percentage of Schizophrenia and Bipolar Disorder Patients Who Earn Minimum Wage or Above. Schizophr Bull. 2016;42:443-447.

29.  Czerniak E, Biegon A, Ziv A, Karnieli-Miller O, Weiser M, Alon U, Citron A. Manipulating the Placebo Response in Experimental Pain by Altering Doctor's Performance Style. Front Psychol. 2016;7:874.

30.  Burshtein S, Dohrenwend BP, Levav I, Werbeloff N, Davidson M, Weiser M. Religiosity as a protective factor against suicidal behaviour. Acta Psychiatr Scand. 2016;133:481-488.

31.  Amiaz R, Rubinstein K, Czerniak E, Karni Y, Weiser M. A Diet and Fitness Program Similarly Affects Weight Reduction in Schizophrenia Patients Treated with Typical or Atypical Medications. Pharmacopsychiatry. 2016;49:112-116.

32.  Amiaz R, Asher E, Rozen G, Czerniak E, Glikson M, Weiser M. Do implantable cardioverter defibrillators contribute to new depression or anxiety symptoms? A retrospective study. Int J Psychiatry Clin Pract. 2016;20:101-105.

33.  Werbeloff N, Dohrenwend BP, Yoffe R, van Os J, Davidson M, Weiser M. The association between negative symptoms, psychotic experiences and later schizophrenia: a population-based longitudinal study. PLoS One. 2015;10:e0119852.

34.  Weiser M, Kapra O, Werbeloff N, Goldberg S, Fenchel D, Reichenberg A, Yoffe R, Ginat K, Fruchter E, Davidson M. A population-based longitudinal study of suicide risk in male schizophrenia patients: Proximity to hospital discharge and the moderating effect of premorbid IQ. Schizophr Res. 2015;169:159-164.

35.  Weiser M, Garibaldi G. Quantifying motivational deficits and apathy: a review of the literature. Eur Neuropsychopharmacol. 2015;25:1060-1081.

36.  Knowles EE, Weiser M, David AS, Glahn DC, Davidson M, Reichenberg A. The puzzle of processing speed, memory, and executive function impairments in schizophrenia: fitting the pieces together. Biol Psychiatry. 2015;78:786-793.

37.  Goldberg S, Werbeloff N, Shelef L, Fruchter E, Weiser M. Risk of suicide among female adolescents with eating disorders: a longitudinal population-based study. Eat Weight Disord. 2015;20:295-300.

38.  Fruchter E, Goldberg S, Fenchel D, Grotto I, Ginat K, Weiser M. The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study. Schizophr Res. 2015;168:292-296.

39.  Feingold D, Weiser M, Rehm J, Lev-Ran S. The association between cannabis use and mood disorders: A longitudinal study. J Affect Disord. 2015;172:211-218.

40.  Chubarov E, Sommerfeld E, Hermesh H, Shoval G, Weiser M, Zalsman G. Dynamic occupation assessment of executive function in adolescents with schizophrenia spectrum disorders: An initial report. Eur Psychiatry. 2015;30:894-899.

41.  Buhnick-Atzil O, Rubinstein K, Tuval-Mashiach R, Fischer S, Fruchter E, Large M, Weiser M. Everyday functioning of male adolescents who later died by suicide: Results of a pilot case-control study using mixed-method analysis. J Affect Disord. 2015;172:116-120.

42.  Amiaz R, Kent I, Rubinstein K, Sela BA, Javitt D, Weiser M. Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study. Isr J Psychiatry Relat Sci. 2015;52:12-15.

43.  Addington J, Stowkowy J, Weiser M. Screening tools for clinical high risk for psychosis. Early Interv Psychiatry. 2015;9:345-356.

44.  Weiser M, Burshtein S, Gershon AA, Marian G, Vlad N, Grecu IG, Tocari E, Tiugan A, Hotineanu M, Davis JM. Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorder. Bipolar Disord. 2014;16:441-447.

45.  Nieman DH, Ruhrmann S, Dragt S, Soen F, van Tricht MJ, Koelman JH, Bour LJ, Velthorst E, Becker HE, Weiser M, Linszen DH, de Haan L. Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophr Bull. 2014;40:1482-1490.

46.  Levi-Belz Y, Gvion Y, Horesh N, Fischel T, Treves I, Or E, Stein-Reisner O, Weiser M, David HS, Apter A. Mental pain, communication difficulties, and medically serious suicide attempts: a case-control study. Arch Suicide Res. 2014;18:74-87.

47.  Gvion Y, Horresh N, Levi-Belz Y, Fischel T, Treves I, Weiser M, David HS, Stein-Reizer O, Apter A. Aggression-impulsivity, mental pain, and communication difficulties in medically serious and medically non-serious suicide attempters. Compr Psychiatry. 2014;55:40-50.

48.  Goldberg S, Werbeloff N, Fruchter E, Portuguese S, Davidson M, Weiser M. IQ and obesity in adolescence: a population-based, cross-sectional study. Pediatr Obes. 2014;9:419-426.

49.  Gigi K, Werbeloff N, Goldberg S, Portuguese S, Reichenberg A, Fruchter E, Weiser M. Borderline intellectual functioning is associated with poor social functioning, increased rates of psychiatric diagnosis and drug use--a cross sectional population based study. Eur Neuropsychopharmacol. 2014;24:1793-1797.

50.  Fruchter E, Kapara O, Reichenberg A, Yoffe R, Fono-Yativ O, Kreiss Y, Davidson M, Weiser M. Longitudinal association between epilepsy and schizophrenia: a population-based study. Epilepsy Behav. 2014;31:291-294.

51.  Fleischman A, Werbeloff N, Yoffe R, Davidson M, Weiser M. Schizophrenia and violent crime: a population-based study. Psychol Med. 2014;44:3051-3057.

52.  Epstein T, Patsopoulos NA, Weiser M. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2014:CD005041.

53.  Seidman SN, Weiser M. Testosterone and mood in aging men. Psychiatr Clin North Am. 2013;36:177-182.

54.  Rabany L, Weiser M, Levkovitz Y. Guilt and depression: two different factors in individuals with negative symptoms of schizophrenia. Eur Psychiatry. 2013;28:327-331.

55.  Nitta M, Kishimoto T, Muller N, Weiser M, Davidson M, Kane JM, Correll CU. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull. 2013;39:1230-1241.

56.  Muller M, Vetter S, Weiser M, Frey F, Ajdacic-Gross V, Stieglitz RD, Rossler W. Precursors of cognitive impairments in psychotic disorders: a population-based study. Psychiatry Res. 2013;210:329-337.

57.  Gelkopf M, Roe D, Werbeloff N, Hasson-Ohayon I, Mueser KT, Caspi A, Weiser M. The prevalence of full and partial posttraumatic stress disorder among people with severe mental illness in Israel. J Nerv Ment Dis. 2013;201:244-250.

58.  Ehrlich-Ben Or S, Hasson-Ohayon I, Feingold D, Vahab K, Amiaz R, Weiser M, Lysaker PH. Meaning in life, insight and self-stigma among people with severe mental illness. Compr Psychiatry. 2013;54:195-200.

59.  Werbeloff N, Drukker M, Dohrenwend BP, Levav I, Yoffe R, van Os J, Davidson M, Weiser M. Self-reported attenuated psychotic symptoms as forerunners of severe mental disorders later in life. Arch Gen Psychiatry. 2012;69:467-475.

60.  Weiser M, Werbeloff N, Dohrenwend BP, Levav I, Yoffe R, Davidson M. Do psychiatric registries include all persons with schizophrenia in the general population? A population-based longitudinal study. Schizophr Res. 2012;135:187-191.

61.  Weiser M, Heresco-Levy U, Davidson M, Javitt DC, Werbeloff N, Gershon AA, Abramovich Y, Amital D, Doron A, Konas S, Levkovitz Y, Liba D, Teitelbaum A, Mashiach M, Zimmerman Y. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia. J Clin Psychiatry. 2012;73:e728-734.

62.  Weiser M, Gershon AA, Rubinstein K, Petcu C, Ladea M, Sima D, Podea D, Keefe RS, Davis JM. A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder. Schizophr Res. 2012;138:35-38.

63.  Sullivan PF, Magnusson C, Reichenberg A, Boman M, Dalman C, Davidson M, Fruchter E, Hultman CM, Lundberg M, Langstrom N, Weiser M, Svensson AC, Lichtenstein P. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 2012;69:1099-1103.

64.  Knowles EE, Weiser M, David AS, Dickinson D, Glahn D, Gold J, Davidson M, Reichenberg A. Dedifferentiation and substitute strategy: deconstructing the processing-speed impairment in schizophrenia. Schizophr Res. 2012;142:129-136.

65.  Kleinhaus K, Harlap S, Perrin MC, Manor O, Weiser M, Harkavy-Friedman JM, Lichtenberg P, Malaspina D. Catatonic schizophrenia: a cohort prospective study. Schizophr Bull. 2012;38:331-337.

66.  Kaymaz N, Drukker M, Lieb R, Wittchen HU, Werbeloff N, Weiser M, Lataster T, van Os J. Do subthreshold psychotic experiences predict clinical outcomes in unselected non-help-seeking population-based samples? A systematic review and meta-analysis, enriched with new results. Psychol Med. 2012;42:2239-2253.

67.  Hasson-Ohayon I, Ehrlich-Ben Or S, Vahab K, Amiaz R, Weiser M, Roe D. Insight into mental illness and self-stigma: the mediating role of shame proneness. Psychiatry Res. 2012;200:802-806.

68.  Weiser M. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase. Am J Psychiatry. 2011;168:761-763.

69.  Rabany L, Weiser M, Werbeloff N, Levkovitz Y. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS. Schizophr Res. 2011;126:226-230.

70.  Kleinhaus K, Harlap S, Perrin M, Manor O, Weiser M, Lichtenberg P, Malaspina D. Age, sex and first treatment of schizophrenia in a population cohort. J Psychiatr Res. 2011;45:136-141.

71.  Goldberg S, Fruchter E, Davidson M, Reichenberg A, Yoffe R, Weiser M. The relationship between risk of hospitalization for schizophrenia, SES, and cognitive functioning. Schizophr Bull. 2011;37:664-670.

72.  Amiaz R, Pope HG, Jr., Mahne T, Kelly JF, Brennan BP, Kanayama G, Weiser M, Hudson JI, Seidman SN. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial. J Sex Marital Ther. 2011;37:243-254.

73.  Weiser M, Zarka S, Werbeloff N, Kravitz E, Lubin G. Cognitive test scores in male adolescent cigarette smokers compared to non-smokers: a population-based study. Addiction. 2010;105:358-363.

74.  Weiser M, Werbeloff N, Levine A, Livni G, Schreiber S, Halperin D, Yoffe R, Davidson M. CNS infection in childhood does not confer risk for later schizophrenia: a case-control study. Schizophr Res. 2010;124:231-235.

75.  Pope HG, Jr., Amiaz R, Brennan BP, Orr G, Weiser M, Kelly JF, Kanayama G, Siegel A, Hudson JI, Seidman SN. Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatment. J Clin Psychopharmacol. 2010;30:126-134.

76.  Lubin G, Werbeloff N, Halperin D, Shmushkevitch M, Weiser M, Knobler HY. Decrease in suicide rates after a change of policy reducing access to firearms in adolescents: a naturalistic epidemiological study. Suicide Life Threat Behav. 2010;40:421-424.

77.  Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PM, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA, Garris M, Otieno FG, Davidson M, Weiser M, Reichenberg A, Davis KL, Friedman JI, Cappola TP, Margulies KB, Rader DJ, Grant SF, Buxbaum JD, Gur RE, Hakonarson H. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc Natl Acad Sci U S A. 2010;107:10584-10589.

78.  Weiser M, Reichenberg A, Werbeloff N, Halperin D, Kravitz E, Yoffe R, Davidson M. Increased number of offspring in first degree relatives of psychotic individuals: a partial explanation for the persistence of psychotic illnesses. Acta Psychiatr Scand. 2009;119:466-471.

79.  Seidman SN, Orr G, Raviv G, Levi R, Roose SP, Kravitz E, Amiaz R, Weiser M. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial. J Clin Psychopharmacol. 2009;29:216-221.

80.  Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, Lopez-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rossler A, Kahn RS. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). Am J Psychiatry. 2009;166:675-682.

81.  Caspi A, Vishne T, Reichenberg A, Weiser M, Dishon A, Lubin G, Shmushkevitz M, Mandel Y, Noy S, Davidson M. Refractive errors and schizophrenia. Schizophr Res. 2009;107:238-241.

82.  Brill N, Levine SZ, Reichenberg A, Lubin G, Weiser M, Rabinowitz J. Pathways to functional outcomes in schizophrenia: the role of premorbid functioning, negative symptoms and intelligence. Schizophr Res. 2009;110:40-46.

83.  Weiser M, Werbeloff N, Vishna T, Yoffe R, Lubin G, Shmushkevitch M, Davidson M. Elaboration on immigration and risk for schizophrenia. Psychol Med. 2008;38:1113-1119.

84.  Weiser M, Reichenberg A, Werbeloff N, Kravitz E, Halperin D, Lubin G, Shmushkevitch M, Yoffe R, Addington J, Davidson M. Self-report of family functioning and risk for psychotic disorders in male adolescents with behavioural disturbances. Acta Psychiatr Scand. 2008;117:225-231.

85.  Weiser M, Reichenberg A, Werbeloff N, Kleinhaus K, Lubin G, Shmushkevitch M, Caspi A, Malaspina D, Davidson M. Advanced parental age at birth is associated with poorer social functioning in adolescent males: shedding light on a core symptom of schizophrenia and autism. Schizophr Bull. 2008;34:1042-1046.

86.  Weiser M, Reichenberg A, Kravitz E, Lubin G, Shmushkevich M, Glahn DC, Gross R, Rabinowitz J, Noy S, Davidson M. Subtle cognitive dysfunction in nonaffected siblings of individuals affected by nonpsychotic disorders. Biol Psychiatry. 2008;63:602-608.

87.  Weiser M, Lubin G, Caspi A, Rabinowitz J, Shmushkevitz M, Yoffe R, Werbeloff N, Halperin D, Davidson M. Dysthymia in male adolescents is associated with increased risk of later hospitalization for psychotic disorders: a historical-prospective cohort study. Early Interv Psychiatry. 2008;2:67-72.

88.  Weiser M, Davidson M. Using clinical data bases to study schizophrenia. Schizophr Bull. 2008;34:1033-1034.

89.  Orr G, Seidman SN, Weiser M, Gershon AA, Dubrov Y, Klein DF. An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia. J Nerv Ment Dis. 2008;196:496-500.

90.  Brill N, Reichenberg A, Weiser M, Rabinowitz J. Validity of the premorbid adjustment scale. Schizophr Bull. 2008;34:981-983.

91.  Weiser M, van Os J, Reichenberg A, Rabinowitz J, Nahon D, Kravitz E, Lubin G, Shmushkevitz M, Knobler HY, Noy S, Davidson M. Social and cognitive functioning, urbanicity and risk for schizophrenia. Br J Psychiatry. 2007;191:320-324.

92.  Weiser M, Reichenberg A, Rabinowitz J, Nahon D, Kravitz E, Lubin G, Knobler HY, Davidson M, Noy S. Impaired reading comprehension and mathematical abilities in male adolescents with average or above general intellectual abilities are associated with comorbid and future psychopathology. J Nerv Ment Dis. 2007;195:883-890.

93.  Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Shmushkevich M, Lubin G, Nahon D, Vishne T, Davidson M. Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs. Schizophr Res. 2007;94:45-49.

94.  Brill N, Reichenberg A, Rabinowitz J, Harary E, Lubin G, Davidson M, Weiser M. Accuracy of self-reported premorbid functioning in schizophrenia. Schizophr Res. 2007;97:103-108.

95.  Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M. Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study. Schizophr Res. 2006;85:49-57.

96.  Reichenberg A, Weiser M, Caspi A, Knobler HY, Lubin G, Harvey PD, Rabinowitz J, Davidson M. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J Clin Exp Neuropsychol. 2006;28:193-207.

97.  Reichenberg A, Gross R, Weiser M, Bresnahan M, Silverman J, Harlap S, Rabinowitz J, Shulman C, Malaspina D, Lubin G, Knobler HY, Davidson M, Susser E. Advancing paternal age and autism. Arch Gen Psychiatry. 2006;63:1026-1032.

98.  Orr G, Weiser M, Polliack M, Raviv G, Tadmor D, Grunhaus L. Effectiveness of sildenafil in treating erectile dysfunction in PTSD patients: a double-blind, placebo-controlled crossover study. J Clin Psychopharmacol. 2006;26:426-430.

99.  Kolevzon A, Weiser M, Gross R, Lubin G, Knobler HY, Schmeidler J, Silverman JM, Reichenberg A. Effects of season of birth on autism spectrum disorders: fact or fiction? Am J Psychiatry. 2006;163:1288-1290.

100.  Hasson-Ohayon I, Walsh S, Roe D, Kravetz S, Weiser M. Personal and interpersonal perceived control and the quality of life of persons with severe mental illness. J Nerv Ment Dis. 2006;194:538-542.

101.  Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M. Insight into psychosis and quality of life. Compr Psychiatry. 2006;47:265-269.

102.  Weiser M, van Os J, Davidson M. Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry. 2005;187:203-205.

103.  Weiser M, Noy S. Interpreting the association between cannabis use and increased risk for schizophrenia. Dialogues Clin Neurosci. 2005;7:81-85.

104.  Weiser M, Kanyas K, Malaspina D, Harvey PD, Glick I, Goetz D, Karni O, Yakir A, Turetsky N, Fennig S, Nahon D, Lerer B, Davidson M. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry. 2005;46:38-42.

105.  Weiser M, Davidson M, Noy S. Comments on risk for schizophrenia. Schizophr Res. 2005;79:15-21.

106.  Riala K, Hakko H, Isohanni M, Jokelainen J, Weiser M, Rasanen P. Poor premorbid school performance is associated with later cigarette smoking among schizophrenia patients. Psychiatry Res. 2005;137:137-141.

107.  Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M. Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry. 2005;62:1297-1304.

108.  Rabinowitz J, Haim R, Reichenberg A, Weiser M, Kaplan Z, Davidson M, Hafner H. Association between functioning in adolescence prior to first admission for schizophrenia and affective disorders and patterns of hospitalizations thereafter. Schizophr Res. 2005;73:185-191.

109.  Malaspina D, Reichenberg A, Weiser M, Fennig S, Davidson M, Harlap S, Wolitzky R, Rabinowitz J, Susser E, Knobler HY. Paternal age and intelligence: implications for age-related genomic changes in male germ cells. Psychiatr Genet. 2005;15:117-125.

110.  Weiser M, Reichenberg A, Rabinowitz J, Knobler HY, Lubin G, Yazvitzky R, Nahon D, Gur RC, Davidson M. Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a population-based study. Acta Psychiatr Scand. 2004;110:471-475.

111.  Weiser M, Reichenberg A, Grotto I, Yasvitzky R, Rabinowitz J, Lubin G, Nahon D, Knobler HY, Davidson M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry. 2004;161:1219-1223.

112.  Weiser M, Knobler H, Lubin G, Nahon D, Kravitz E, Caspi A, Noy S, Knobler HY, Davidson M. Body mass index and future schizophrenia in Israeli male adolescents. J Clin Psychiatry. 2004;65:1546-1549.

113.  Kaplan H, Bar-Meir E, Gilboa D, Yaffe B, Rabinovitch O, Karasik A, Weiser M, Madgar I, Ramon J, Schiff E, Tsur H, Orenstein A. [Sex reassignment surgery]. Harefuah. 2004;143:500-504, 549.

114.  Heydebrand G, Weiser M, Rabinowitz J, Hoff AL, DeLisi LE, Csernansky JG. Correlates of cognitive deficits in first episode schizophrenia. Schizophr Res. 2004;68:1-9.

115.  Davidson M, Weiser M. Prodromal schizophrenia: the dilemma of prediction and early intervention. CNS Spectr. 2004;9:578.

116.  Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Caspi A, Yasvizky R, Mark M, Knobler HY, Nahon D, Davidson M. Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia. Biol Psychiatry. 2003;54:655-660.

117.  Weiser M, Noy S, Kaplan Z, Reichenberg A, Yazvitsky R, Nahon D, Grotto I, Knobler HY. Generalized cognitive impairment in male adolescents with schizotypal personality disorder. Am J Med Genet B Neuropsychiatr Genet. 2003;116B:36-40.

118.  Soares-Weiser K, Weiser M, Davidson M. [Use of cannabis in adolescence and risk of schizophrenia]. Rev Bras Psiquiatr. 2003;25:131-132.

119.  Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Kaplan Z, Knobler H, Davidson-Sagi N, Davidson M. Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophr Res. 2003;65:87-94.

120.  Weiser M, Rotmensch HH, Korczyn AD, Hartman R, Cicin-Sain A, Anand R, Rivastigmine-Risperidone Study G. A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances. Int J Geriatr Psychiatry. 2002;17:343-346.

121.  Weiser M, Knobler HY, Noy S, Kaplan Z. Clinical characteristics of adolescents later hospitalized for schizophrenia. Am J Med Genet. 2002;114:949-955.

122.  Reichenberg A, Weiser M, Rabinowitz J, Caspi A, Schmeidler J, Mark M, Kaplan Z, Davidson M. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry. 2002;159:2027-2035.

123.  Kaplan Z, Weiser M, Reichenberg A, Rabinowitz J, Caspi A, Bodner E, Zohar J. Motivation to serve in the military influences vulnerability to future posttraumatic stress disorder. Psychiatry Res. 2002;109:45-49.

124.  Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Bodner E, Nahon D, Davidson M. Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia. Arch Gen Psychiatry. 2001;58:959-964.

125.  Weiser M, Shneider-Beeri M, Nakash N, Brill N, Bawnik O, Reiss S, Hocherman S, Davidson M. Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS? Schizophr Res. 2000;46:81-89.

126.  Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Nahon D, Davidson M. Gender differences in premorbid cognitive performance in a national cohort of schizophrenic patients. Schizophr Res. 2000;45:185-190.

127.  Reichenberg A, Rabinowitz J, Weiser M, Mark M, Kaplan Z, Davidson M. Premorbid functioning in a national population of male twins discordant for psychoses. Am J Psychiatry. 2000;157:1514-1516.

128.  Rabinowitz J, Reichenberg A, Weiser M, Mark M, Kaplan Z, Davidson M. Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital. Cross-sectional analysis. Br J Psychiatry. 2000;177:26-32.

129.  Davidson M, Weiser M. Early diagnosis of schizophrenia--the first step towards secondary prevention. Acta Psychiatr Scand Suppl. 2000;400:7-10.

130.  Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999;156:1328-1335.

131.  Weiser M, Lapidus R, Abramowitch Y, Davidson M. [The electroencephalogram in psychiatric patients]. Harefuah. 1998;135:8-9, 88, 87.

132.  Weiser M, Hendler T, Prohovnik I, Davidson M. Diagnostic yield of brain CT in a limited-access environment. Int J Psychiatry Clin Pract. 1998;2:279-282.

133.  Kutz I, Weiser M, David D. Possible pitfalls in the diagnosis of acute myocardial infarction in acutely psychotic patients. Isr J Psychiatry Relat Sci. 1997;34:311-314.

134.  Weiser M, Kutz I, Kutz SJ, Weiser D. Psychotherapeutic aspects of the martial arts. Am J Psychother. 1995;49:118-127.

135.  Weiser M, Levkowitch Y, Shalom S, Neuman M. [Emotional reactions of psychiatric staff to violent patients]. Harefuah. 1994;126:642-645, 691.

136.  Weiser M, Levkowitch Y, Neuman M, Yehuda S. Decrease of serum iron in acutely psychotic schizophrenic patients. Int J Neurosci. 1994;78:49-52.

137.  Weiser M, Levy A, Neuman M. Ear stuffing: an unusual form of self-mutilation. J Nerv Ment Dis. 1993;181:587-588.

138.  Levkowitch Y, Weiser M, Levy A, Neumann M. [Involuntary outpatient commitment: ethical and legal aspects]. Harefuah. 1993;124:669-672, 740.

139.  Lefkovitch Y, Weiser M, Levy A. Involuntary outpatient commitment: ethics and problems. Med Law. 1993;12:213-220.

140.  Yodfat Y, Weiser M, Kreisel M, Bachrach U. Diamine and polyamine levels in the urine of healthy adults. Clin Chim Acta. 1988;176:107-113.

141.  Weiser MB, Razin M, Stein WD. Kinetic tests of models for sugar transport in human erythrocytes and a comparison of fresh and cold-stored cells. Biochim Biophys Acta. 1983;727:379-388.

 

In Press:

1. Weiser M, Levi L, Zamora D, Biegon A, SanGiovanni JP, Davidson M, Burshtein S, Gonen I, Radu P, Hemi R, Ryan T, Davis J. Effect of adjunctive estradiol on schizophrenia among women of childbearing age: A randomized controlled trial  JAMA Psychiatry, In Press

2. Weiser M, Fenchel D, Frenkel O, Fruchter E, Burshtein S, Ben Yehuda A, Yoffe R, Bergman T, Reichenberg A, Davidson A, Sandin S, Understanding the Association between Advanced Paternal Age and Schizophrenia and Bipolar disorder. Psychological Medicine, In Press

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>
Tel Aviv University
P.O. Box 39040, Tel Aviv 6997801